Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kimberly Jordan

Concepts (299)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
7
2024
565
1.280
 Why?
Tumor Microenvironment
11
2024
674
1.270
 Why?
T-Lymphocytes
11
2022
1996
1.160
 Why?
Cancer Vaccines
7
2021
172
1.160
 Why?
Myeloid-Derived Suppressor Cells
5
2023
66
1.100
 Why?
Antigens, Neoplasm
6
2021
319
0.720
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
34
0.690
 Why?
Receptors, Antigen, T-Cell
7
2021
718
0.680
 Why?
Cytoreduction Surgical Procedures
1
2020
63
0.660
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1692
0.660
 Why?
Baculoviridae
3
2009
44
0.650
 Why?
Chemotherapy, Adjuvant
1
2020
389
0.620
 Why?
Image Processing, Computer-Assisted
1
2023
752
0.610
 Why?
Neoadjuvant Therapy
2
2022
404
0.600
 Why?
Insecta
3
2009
67
0.590
 Why?
Extracellular Vesicles
1
2020
146
0.580
 Why?
Granulocytes
1
2017
80
0.530
 Why?
Melanoma
4
2023
760
0.520
 Why?
Pancreatic Cyst
1
2017
60
0.500
 Why?
Lymphocyte Activation
4
2017
1142
0.500
 Why?
Monocytes
2
2020
563
0.460
 Why?
Spleen
1
2017
514
0.450
 Why?
CD8-Positive T-Lymphocytes
7
2024
900
0.450
 Why?
Vaccines
2
2010
406
0.440
 Why?
Programmed Cell Death 1 Receptor
3
2022
249
0.440
 Why?
Neoplasms
6
2017
2671
0.430
 Why?
Myeloid Cells
2
2020
148
0.420
 Why?
Vaccines, Subunit
2
2012
49
0.410
 Why?
Tomography, X-Ray Computed
1
2023
2691
0.410
 Why?
Colorectal Neoplasms
3
2024
806
0.400
 Why?
Histone-Lysine N-Methyltransferase
2
2024
136
0.390
 Why?
Complementarity Determining Regions
1
2012
51
0.380
 Why?
Xenograft Model Antitumor Assays
6
2024
872
0.350
 Why?
Benzimidazoles
2
2024
170
0.340
 Why?
Gamma Rays
2
2021
57
0.340
 Why?
Cell Line, Tumor
9
2024
3412
0.330
 Why?
Antineoplastic Agents, Immunological
4
2020
190
0.320
 Why?
Inflammation
1
2020
2837
0.310
 Why?
Mice
21
2024
17787
0.290
 Why?
Breast Neoplasms
1
2020
2253
0.290
 Why?
Pancreatic Neoplasms
3
2021
938
0.280
 Why?
Immunotherapy
5
2021
641
0.280
 Why?
Mice, Inbred BALB C
8
2021
1272
0.280
 Why?
H-2 Antigens
1
2008
115
0.280
 Why?
Carcinoma, Pancreatic Ductal
2
2021
289
0.270
 Why?
Antigens
1
2009
357
0.270
 Why?
Cell Proliferation
7
2024
2475
0.270
 Why?
Proteome
2
2022
472
0.260
 Why?
Tumor Escape
2
2017
42
0.260
 Why?
Antibodies, Monoclonal, Humanized
2
2024
804
0.260
 Why?
Peptide Library
4
2013
92
0.260
 Why?
Survival Analysis
4
2021
1325
0.260
 Why?
Peptides
4
2021
985
0.260
 Why?
Female
28
2025
73304
0.250
 Why?
Vaccination
3
2010
1381
0.250
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2024
115
0.250
 Why?
Transcriptome
2
2022
971
0.240
 Why?
Humans
43
2025
137585
0.230
 Why?
Lung Neoplasms
3
2024
2526
0.230
 Why?
Lupus Nephritis
1
2025
63
0.230
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2025
95
0.230
 Why?
Drug Resistance, Neoplasm
3
2024
801
0.230
 Why?
Models, Biological
2
2021
1783
0.230
 Why?
Major Histocompatibility Complex
4
2021
227
0.230
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
210
0.220
 Why?
Disease Models, Animal
5
2024
4295
0.220
 Why?
Animals
24
2024
36940
0.220
 Why?
Tryptophan Oxygenase
1
2024
34
0.220
 Why?
Keratins
1
2024
173
0.210
 Why?
Bevacizumab
1
2024
138
0.210
 Why?
Cystadenocarcinoma, Serous
1
2024
77
0.210
 Why?
Interferons
2
2022
202
0.210
 Why?
Signal-To-Noise Ratio
1
2023
67
0.210
 Why?
Neoplasms, Experimental
2
2021
176
0.200
 Why?
Small Cell Lung Carcinoma
1
2024
96
0.200
 Why?
Artifacts
1
2023
129
0.200
 Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1081
0.200
 Why?
Prognosis
5
2024
4030
0.200
 Why?
Dendritic Cells
4
2020
483
0.200
 Why?
Fallopian Tubes
1
2022
31
0.200
 Why?
Ephrin-B2
2
2021
47
0.190
 Why?
Fibrosis
2
2024
552
0.190
 Why?
Tretinoin
2
2023
123
0.190
 Why?
Neoplasms, Second Primary
1
2023
118
0.180
 Why?
Flow Cytometry
5
2022
1178
0.180
 Why?
Blood
1
2022
107
0.180
 Why?
Mycosis Fungoides
1
2021
61
0.180
 Why?
Synovial Membrane
1
2022
117
0.180
 Why?
Precision Medicine
1
2025
429
0.180
 Why?
Gene Expression Profiling
3
2021
1774
0.180
 Why?
ADAM10 Protein
1
2021
30
0.170
 Why?
Ovary
1
2022
221
0.170
 Why?
Seroconversion
1
2021
46
0.170
 Why?
Middle Aged
11
2024
33479
0.170
 Why?
Proteomics
3
2024
1111
0.170
 Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.170
 Why?
Oligonucleotides, Antisense
1
2020
112
0.170
 Why?
Databases, Genetic
1
2021
237
0.160
 Why?
Eosinophilic Esophagitis
1
2024
325
0.160
 Why?
Immunity
1
2020
143
0.160
 Why?
Splenectomy
1
2020
62
0.160
 Why?
Macrophages
2
2024
1547
0.160
 Why?
Radiation Injuries
1
2021
145
0.160
 Why?
Diagnostic Imaging
1
2022
332
0.160
 Why?
Radiosurgery
1
2022
344
0.160
 Why?
Cell Adhesion
1
2020
466
0.150
 Why?
Case-Control Studies
3
2022
3556
0.150
 Why?
Survival Rate
2
2021
1972
0.150
 Why?
Receptor, EphB4
1
2019
34
0.150
 Why?
Adrenal Cortex Neoplasms
1
2020
63
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
209
0.150
 Why?
Neoplasm Invasiveness
1
2020
510
0.150
 Why?
Adrenocortical Carcinoma
1
2020
65
0.150
 Why?
STAT3 Transcription Factor
1
2020
206
0.150
 Why?
T-Lymphocytes, Regulatory
3
2020
385
0.150
 Why?
Cell Communication
1
2020
315
0.150
 Why?
Papillomavirus Infections
1
2022
325
0.150
 Why?
Isoxazoles
1
2018
54
0.150
 Why?
Ipilimumab
1
2018
33
0.150
 Why?
Interferon-alpha
1
2019
198
0.150
 Why?
Multiple Sclerosis
1
2024
455
0.140
 Why?
Autoantigens
1
2021
430
0.140
 Why?
Biomarkers, Tumor
2
2022
1276
0.140
 Why?
Mice, Transgenic
3
2024
2167
0.140
 Why?
Immunophenotyping
3
2017
318
0.140
 Why?
Metabolome
1
2021
350
0.140
 Why?
Antigens, CD19
1
2018
123
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
87
0.140
 Why?
Colonic Neoplasms
2
2012
258
0.140
 Why?
Drug Discovery
1
2018
142
0.140
 Why?
Combined Modality Therapy
1
2020
1236
0.140
 Why?
Histone Deacetylase Inhibitors
1
2019
210
0.130
 Why?
Head and Neck Neoplasms
1
2022
606
0.130
 Why?
Oxidation-Reduction
1
2020
1060
0.130
 Why?
Problem-Based Learning
1
2017
92
0.130
 Why?
Spodoptera
2
2021
40
0.130
 Why?
Students, Pharmacy
1
2017
97
0.130
 Why?
Adult
8
2024
37929
0.130
 Why?
Adipose Tissue
1
2020
635
0.130
 Why?
Cell Count
1
2017
324
0.130
 Why?
Triple Negative Breast Neoplasms
1
2019
202
0.120
 Why?
Algorithms
1
2023
1704
0.120
 Why?
Multiple Myeloma
1
2018
252
0.120
 Why?
Signal Transduction
4
2024
5079
0.120
 Why?
Cytotoxicity, Immunologic
2
2020
224
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
289
0.120
 Why?
Neoplasm Recurrence, Local
1
2021
1079
0.120
 Why?
Immunotherapy, Adoptive
1
2018
327
0.110
 Why?
Perception
1
2017
359
0.110
 Why?
Tumor Cells, Cultured
3
2021
955
0.110
 Why?
Membrane Proteins
1
2021
1164
0.110
 Why?
Aged
6
2024
23961
0.110
 Why?
Liver Neoplasms
1
2020
786
0.110
 Why?
Mice, Nude
3
2020
698
0.110
 Why?
Skin Neoplasms
1
2021
855
0.110
 Why?
Blood Cell Count
1
2013
55
0.110
 Why?
Lipopolysaccharide Receptors
1
2013
85
0.100
 Why?
Prostatic Neoplasms
1
2020
1043
0.100
 Why?
Young Adult
3
2021
13209
0.100
 Why?
Arthritis, Rheumatoid
1
2022
1167
0.100
 Why?
Down Syndrome
1
2019
496
0.100
 Why?
Interferon-gamma
2
2021
789
0.100
 Why?
Immunohistochemistry
3
2022
1738
0.100
 Why?
Apoptosis
4
2024
2553
0.100
 Why?
Male
11
2024
67762
0.090
 Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
 Why?
Disease Progression
2
2024
2757
0.090
 Why?
Epitopes, T-Lymphocyte
1
2012
181
0.090
 Why?
Cells, Cultured
2
2017
4193
0.090
 Why?
Datasets as Topic
2
2022
121
0.090
 Why?
B7-H1 Antigen
2
2024
217
0.090
 Why?
Follow-Up Studies
1
2020
5131
0.090
 Why?
Curriculum
1
2017
992
0.090
 Why?
Transcription Factors
1
2018
1719
0.080
 Why?
Neoplasm Proteins
1
2013
434
0.080
 Why?
Immunodominant Epitopes
1
2010
27
0.080
 Why?
Biomarkers
4
2024
4149
0.080
 Why?
Neoplasm Staging
1
2013
1389
0.080
 Why?
Genes, MHC Class I
1
2009
35
0.080
 Why?
Genetic Engineering
1
2009
93
0.070
 Why?
Complement System Proteins
2
2022
327
0.070
 Why?
Histocompatibility Antigens Class I
1
2010
203
0.070
 Why?
Cell Survival
2
2024
1120
0.070
 Why?
Histocompatibility Antigen H-2D
1
2008
21
0.070
 Why?
Cross-Priming
1
2008
15
0.070
 Why?
CD11c Antigen
1
2008
41
0.070
 Why?
Adjuvants, Immunologic
1
2009
226
0.070
 Why?
Molecular Targeted Therapy
2
2020
411
0.070
 Why?
RNA, Messenger
3
2024
2833
0.060
 Why?
Cell Culture Techniques
1
2009
363
0.060
 Why?
Aged, 80 and over
2
2020
7635
0.060
 Why?
Nephrocalcinosis
1
2025
13
0.060
 Why?
Immune Tolerance
1
2008
363
0.060
 Why?
Adolescent
2
2025
21513
0.060
 Why?
Gene Expression
2
2022
1502
0.060
 Why?
Ligands
2
2022
664
0.060
 Why?
Cancer-Associated Fibroblasts
1
2024
20
0.060
 Why?
Neuroendocrine Cells
1
2024
32
0.050
 Why?
Histocompatibility Antigens
1
2024
105
0.050
 Why?
Cell Line
1
2010
2847
0.050
 Why?
Microsatellite Repeats
1
2024
168
0.050
 Why?
Cell Differentiation
1
2011
1991
0.050
 Why?
Neoplasm Grading
1
2024
307
0.050
 Why?
Kynurenine
1
2024
114
0.050
 Why?
Imidazoles
1
2024
238
0.050
 Why?
Neuroendocrine Tumors
1
2024
116
0.050
 Why?
Tryptophan
1
2024
183
0.050
 Why?
Mice, Inbred C57BL
3
2021
5757
0.050
 Why?
Sf9 Cells
1
2021
9
0.050
 Why?
CD47 Antigen
1
2021
38
0.050
 Why?
Tissue Distribution
1
2022
332
0.050
 Why?
Autophagy
1
2024
284
0.040
 Why?
Lymphocytes
2
2020
397
0.040
 Why?
Hypoalbuminemia
1
2021
30
0.040
 Why?
Access to Information
1
2021
49
0.040
 Why?
Ranolazine
1
2020
25
0.040
 Why?
Carcinogenesis
1
2022
217
0.040
 Why?
Cell- and Tissue-Based Therapy
1
2021
81
0.040
 Why?
Animals, Genetically Modified
1
2002
240
0.040
 Why?
Cluster Analysis
1
2022
499
0.040
 Why?
Seroepidemiologic Studies
1
2021
165
0.040
 Why?
Enzyme Inhibitors
1
2024
840
0.040
 Why?
Data Mining
1
2021
116
0.040
 Why?
Receptors, CCR
1
2020
8
0.040
 Why?
RNA, Viral
1
2024
656
0.040
 Why?
Cytokines
3
2018
2085
0.040
 Why?
Platelet Count
1
2020
86
0.040
 Why?
Basophils
1
2020
73
0.040
 Why?
Hematopoiesis
1
2021
192
0.040
 Why?
Lymphocyte Subsets
1
2020
87
0.040
 Why?
Interleukin-6
1
2024
778
0.040
 Why?
Tumor Burden
1
2020
309
0.040
 Why?
Autoimmunity
1
2025
908
0.040
 Why?
Swine
1
2002
775
0.040
 Why?
Leukocyte Count
1
2020
329
0.040
 Why?
Mutation
1
2010
3958
0.040
 Why?
Postoperative Period
1
2020
342
0.040
 Why?
Pancreaticoduodenectomy
1
2020
164
0.040
 Why?
Biological Availability
1
2018
148
0.040
 Why?
Automation
1
2018
95
0.040
 Why?
Immunoglobulin G
1
2003
893
0.040
 Why?
Radiotherapy
1
2019
201
0.040
 Why?
Gene Knockdown Techniques
1
2019
327
0.040
 Why?
Killer Cells, Natural
1
2021
449
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2024
1396
0.040
 Why?
Complement Activation
1
2021
415
0.030
 Why?
Inpatients
1
2022
500
0.030
 Why?
Kidney
1
2025
1468
0.030
 Why?
Structure-Activity Relationship
1
2018
570
0.030
 Why?
Aging
1
2008
1864
0.030
 Why?
Molecular Structure
1
2018
489
0.030
 Why?
B-Lymphocytes
1
2003
847
0.030
 Why?
Lipid Metabolism
1
2020
518
0.030
 Why?
Homeostasis
1
2021
621
0.030
 Why?
Drug Delivery Systems
1
2020
365
0.030
 Why?
Protein Domains
1
2018
289
0.030
 Why?
Cell Movement
1
2021
967
0.030
 Why?
Administration, Oral
1
2018
816
0.030
 Why?
Education, Pharmacy
1
2017
120
0.030
 Why?
Comorbidity
1
2021
1622
0.030
 Why?
Metabolomics
1
2021
678
0.030
 Why?
Educational Measurement
1
2017
289
0.030
 Why?
Dose-Response Relationship, Drug
1
2018
2057
0.030
 Why?
Severity of Illness Index
1
2022
2828
0.030
 Why?
Neutrophils
1
2019
1238
0.030
 Why?
Program Evaluation
1
2017
898
0.030
 Why?
Retrospective Studies
2
2021
15657
0.020
 Why?
Cross Reactions
1
2012
133
0.020
 Why?
Antineoplastic Agents
1
2024
2129
0.020
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
56
0.020
 Why?
Culture Media, Conditioned
1
2011
110
0.020
 Why?
Hospitalization
1
2021
2199
0.020
 Why?
Endocytosis
1
2011
172
0.020
 Why?
Universities
1
2013
433
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
852
0.020
 Why?
Treatment Outcome
1
2024
10811
0.020
 Why?
In Vitro Techniques
1
2011
1092
0.020
 Why?
Prospective Studies
1
2021
7604
0.020
 Why?
Enterotoxins
1
2006
88
0.020
 Why?
T-Lymphocytes, Cytotoxic
1
2006
173
0.020
 Why?
Drug Design
1
2006
167
0.010
 Why?
DNA Primers
1
2006
515
0.010
 Why?
Antigen Presentation
1
2006
218
0.010
 Why?
Blood Cells
1
2003
40
0.010
 Why?
CD40 Ligand
1
2003
41
0.010
 Why?
Colorado
1
2013
4565
0.010
 Why?
Coculture Techniques
1
2003
239
0.010
 Why?
Amino Acid Sequence
1
2006
2139
0.010
 Why?
Child
1
2021
21935
0.010
 Why?
Molecular Sequence Data
1
2006
2900
0.010
 Why?
Antibody Formation
1
2003
298
0.010
 Why?
Immunoglobulins
1
2002
171
0.010
 Why?
Organ Size
1
2002
477
0.010
 Why?
Mice, Knockout
1
2008
3015
0.010
 Why?
Cattle
1
2003
984
0.010
 Why?
Echocardiography
1
2002
642
0.010
 Why?
Birth Weight
1
2002
516
0.010
 Why?
Placenta
1
2002
750
0.010
 Why?
Phenotype
1
2002
3196
0.010
 Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (299) concept(s)
_
Co-Authors Expand Description
See all (133) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)